Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/117946
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Morton, J. | - |
dc.contributor.author | Bao, S. | - |
dc.contributor.author | Vanags, L. | - |
dc.contributor.author | Tsatralis, T. | - |
dc.contributor.author | Ridiandries, A. | - |
dc.contributor.author | Siu, C. | - |
dc.contributor.author | Ng, K. | - |
dc.contributor.author | Tan, J. | - |
dc.contributor.author | Celermajer, D. | - |
dc.contributor.author | Ng, M. | - |
dc.contributor.author | Bursill, C. | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | JACC: Basic to Translational Science, 2018; 3(2):187-199 | - |
dc.identifier.issn | 2452-302X | - |
dc.identifier.issn | 2452-302X | - |
dc.identifier.uri | http://hdl.handle.net/2440/117946 | - |
dc.description.abstract | Preclinical studies have shown benefit of apolipoprotein A-I (apoA-I)/high-density lipoprotein (HDL) raising in atherosclerosis; however, this has not yet translated into a successful clinical therapy. Our studies demonstrate that apoA-I raising is more effective at reducing early-stage atherosclerosis than late-stage disease, indicating that the timing of HDL raising is a critical factor in its atheroprotective effects. To date, HDL-raising clinical trials have only been performed in aged patients with advanced atherosclerotic disease. Our findings therefore provide insight, related to important temporal aspects of HDL raising, as to why the clinical trials have thus far been largely neutral. | - |
dc.description.statementofresponsibility | Jamie Morton, Shisan Bao, Laura Z. Vanags, Tania Tsatralis, Anisyah Ridiandries, Chung-Wah Siu, Kwong-Man Ng, Joanne T.M. Tan, David S. Celermajer, Martin K.C. Ng, Christina A. Bursill | - |
dc.language.iso | en | - |
dc.publisher | Elsevier | - |
dc.rights | © 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. | - |
dc.source.uri | http://dx.doi.org/10.1016/j.jacbts.2017.11.004 | - |
dc.subject | Atherosclerosis, cholesterol; high-density lipoproteins | - |
dc.title | Strikingly different atheroprotective effects of apolipoprotein A-I in early- versus late-stage atherosclerosis | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.jacbts.2017.11.004 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/598402 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/632512 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Tan, J. [0000-0003-1875-4882] | - |
dc.identifier.orcid | Bursill, C. [0000-0002-0682-8760] [0000-0003-1087-7781] | - |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.